Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Borsi

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Cancer|July 1, 1987
A comparative study on the pharmacokinetics of methotrexate in a dose range of 0.5 g to 33.6 g/m2 in children with acute lymphoblastic leukemiaJ D Borsi, P J Moe
Acta Paediatrica Scandinavica. Supplement|January 1, 1987
New aspects of clinical and cellular pharmacodynamics of methotrexate with special emphasis on its role in the treatment of acute lymphoblastic leukemia in childrenJ D Borsi, P J Moe
Cancer|December 15, 1987
Systemic clearance of methotrexate in the prognosis of acute lymphoblastic leukemia in childrenJ D Borsi, P J Moe
Cancer Chemotherapy and Pharmacology|January 1, 1987
Prognostic importance of systemic clearance of methotrexate in childhood acute lymphoblastic leukemiaJ D Borsi, T Revesz, D Schuler
Cancer Chemotherapy and Pharmacology|January 1, 1988
PharmCalc: program for the calculation of clinical pharmacokinetic parameters of methotrexateJ D Borsi, O Klepp, P J Moe
Cancer Chemotherapy and Pharmacology|January 1, 1988
Methotrexate administered by 6-h and 24-h infusion: a pharmacokinetic comparisonJ D Borsi, D Schuler, P J Moe
Pediatric Hematology and Oncology|March 1, 1994
Human recombinant granulocyte-macrophage colony-stimulating factor in pediatric oncology practiceT Ferencz, C Csaki, D Schuler, et al.
Anti-Cancer Drugs|January 1, 1996
Administration of Ethyol (amifostine) to a child with medulloblastoma to ameliorate hematological toxicity of high dose carboplatinJ D Borsi, C Csaki, T Ferencz, et al.
Pediatric Hematology and Oncology|January 1, 1996
Childhood leukemia and statistical characteristics in 0- to 18-year-old patients in Hungary, diagnosed between 1988 and 1992E Apjok, R Koos, J D Borsi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 1998
Recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia in children with malignant solid tumoursC Csáki, T Ferencz, D Schuler, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cancer|July 1, 1987
A comparative study on the pharmacokinetics of methotrexate in a dose range of 0.5 g to 33.6 g/m2 in children with acute lymphoblastic leukemiaJ D Borsi, P J Moe
Acta Paediatrica Scandinavica. Supplement|January 1, 1987
New aspects of clinical and cellular pharmacodynamics of methotrexate with special emphasis on its role in the treatment of acute lymphoblastic leukemia in childrenJ D Borsi, P J Moe
Cancer|December 15, 1987
Systemic clearance of methotrexate in the prognosis of acute lymphoblastic leukemia in childrenJ D Borsi, P J Moe
Cancer Chemotherapy and Pharmacology|January 1, 1987
Prognostic importance of systemic clearance of methotrexate in childhood acute lymphoblastic leukemiaJ D Borsi, T Revesz, D Schuler
Cancer Chemotherapy and Pharmacology|January 1, 1988
PharmCalc: program for the calculation of clinical pharmacokinetic parameters of methotrexateJ D Borsi, O Klepp, P J Moe
Cancer Chemotherapy and Pharmacology|January 1, 1988
Methotrexate administered by 6-h and 24-h infusion: a pharmacokinetic comparisonJ D Borsi, D Schuler, P J Moe
Pediatric Hematology and Oncology|March 1, 1994
Human recombinant granulocyte-macrophage colony-stimulating factor in pediatric oncology practiceT Ferencz, C Csaki, D Schuler, et al.
Anti-Cancer Drugs|January 1, 1996
Administration of Ethyol (amifostine) to a child with medulloblastoma to ameliorate hematological toxicity of high dose carboplatinJ D Borsi, C Csaki, T Ferencz, et al.
Pediatric Hematology and Oncology|January 1, 1996
Childhood leukemia and statistical characteristics in 0- to 18-year-old patients in Hungary, diagnosed between 1988 and 1992E Apjok, R Koos, J D Borsi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 1998
Recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia in children with malignant solid tumoursC Csáki, T Ferencz, D Schuler, et al.
Pageof 3